Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. - Wikidata - wikimedia - TriplyDB

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.

http://www.wikidata.org/entity/Q37250253

about

Glioblastoma cancer stem cells: Biomarker and therapeutic advances Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors.Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1.Wnt activation promotes neuronal differentiation of glioblastoma The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathway.Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones.Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas.Expression of the chitinase family glycoprotein YKL-40 in undifferentiated, differentiated and trans-differentiated mesenchymal stem cells.ASYMMETRIC CELL DIVISION: IMPLICATIONS FOR GLIOMA DEVELOPMENT AND TREATMENT.Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence.Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.A Prominin-1-Rich Pediatric Glioblastoma: Biologic Behavior Is Determined by Oxygen Tension-Modulated CD133 Expression but Not Accompanied by Underlying Molecular Profiles.Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.Emerging targets for glioblastoma stem cell therapy Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A Novel association between microglia and stem cells in human gliomas: A contributor to tumour proliferation?Label-retaining assay enriches tumor-initiating cells in glioblastoma spheres cultivated in serum-free medium.Essential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrence.Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor.Radioresistance of glioma stem cells: intrinsic characteristic or property of the 'microenvironment-stem cell unit'?Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.Peptide vaccines for the treatment of glioblastoma.Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target.Therapeutic antibodies against cancer stem cells: a promising approach.A comprehensive profile of recurrent glioblastoma.CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro.Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers.

P2860

Q26859782-D2632CE8-BA6F-4AA4-AB80-8EE5D31E448D Q26998561-B8EBB02F-DEAF-4049-BB7C-935A33BBBBCE Q30413140-5A524F45-294A-4C49-98E2-EA6FF6995419 Q30997872-3C49FE95-1894-42D5-A818-2F7BD18DE115 Q33580112-D6568FFE-3C6C-4BF1-AC9B-D834229F92CF Q33903166-E7D83F16-BCEE-42B8-AEB8-9D64AC197801 Q34046737-00CB411C-6EA5-4240-BE35-5F724094B5E5 Q34047392-525E0185-2A45-4E9D-B83E-A4D43CC288BA Q34184430-80616AE3-03CA-4DD6-B0B9-EFF3DF82DC1B Q34720622-B17F4403-8AA9-4DFB-A311-A520F747FB36 Q34723950-1AC92ADB-3713-453A-9337-942458229316 Q35048997-87F572B3-B80A-4251-9280-456920654833 Q35060849-E7235A69-D399-42BB-A15C-584C55DA712D Q35631598-6A0EC62B-33AA-47E4-A238-6F3720B0C203 Q35687115-017EBA11-3B95-4C5D-BDC6-242E8097A043 Q35794896-C8C67E68-34F0-49AB-B3DD-825976146485 Q35823287-06E99F20-A87F-4B73-A0B7-03B157F7CEE1 Q36061775-6C40789A-FFCC-4BA0-9E42-069BBA77CEDD Q36259173-D3E94380-65CF-47E8-A55A-6D2AA37108D0 Q36280796-16147788-3A95-4D53-98EB-191065B1FCA4 Q36502009-87219EAD-5C5C-46CD-82C2-0D490B9CDFDA Q36566768-C751215D-D0AA-40FA-B03F-A20A389640E8 Q36586507-2D8E8CA9-7B7C-4CAA-A7E3-8B473A91E3FF Q36588945-0BA4117B-00D5-4D39-A15F-9087E017D7E3 Q36850429-DEA49CC6-18FE-435A-A602-827E1BF4F56E Q36873852-BC74F897-5DDB-4539-AE7D-439DB2765646 Q37106630-21FE69AB-7A90-4112-808F-627D1982AE97 Q37132697-393D601F-0137-412B-9682-35813110B26D Q37658825-21B2D43D-5E56-4BA5-A888-B714C49234A3 Q37705532-7DFB61A7-CCBD-4CC2-B34B-AA33D7DC6289 Q37887286-E82C7463-E805-45BD-9CF2-5436958C2712 Q38066416-94550D12-8E48-4D2C-B97A-1496DB988FAA Q38180344-25DED940-CA3A-444B-83D6-F8C0D98B69B9 Q38285889-835B6B30-E0FE-4354-89D3-EC12291F3047 Q38287518-06AD98F2-ECF6-4484-8AD4-C0FE73236062 Q38637435-5BC2253A-AEAB-4CC6-A2EC-59A21C21336B Q38797345-A5287293-379F-410C-966A-ECC5E79819C3 Q38893170-B3039732-2577-4896-84B0-C60F49909C93 Q38943301-0D0573C1-1C75-4D45-8378-F8E3FCBC5A09 Q38952768-9106344D-4D3A-411E-A5DA-9F51F85B8FA1

P2860

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.

http://www.wikidata.org/entity/Q37250253

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Molecular properties of CD133+ ...... actory recurrent brain tumors.

@en

Molecular properties of CD133+ ...... actory recurrent brain tumors.

@nl

type

label

Molecular properties of CD133+ ...... actory recurrent brain tumors.

@en

Molecular properties of CD133+ ...... actory recurrent brain tumors.

@nl

prefLabel

Molecular properties of CD133+ ...... actory recurrent brain tumors.

@en

Molecular properties of CD133+ ...... actory recurrent brain tumors.

@nl

P1433

Q37250253-566E84DC-FFED-4E56-A203-ABDE254862E6

P1476

Q37250253-5541E29E-070F-450E-9F12-E29611EFFC29

P2093

Q37250253-1778825B-EAE4-4E99-97F3-10C41486867E

Q37250253-1794BABE-540E-4E70-ABB9-D7E7D4511045

Q37250253-3AAF2808-D7C5-4105-A190-E411F54C8F76

Q37250253-3CD646F4-E5E9-459E-9EB5-EF47848C8061

Q37250253-55DF91FB-7DCA-4FF3-878B-F2215B48E580

Q37250253-562CD218-3C7F-40D9-BD70-125E305297B8

Q37250253-72B4C54A-3212-48AA-B8E4-5FFF19EA0757

Q37250253-A7AA075C-8C75-410B-9BD9-1DA2AFEA7EB3

Q37250253-AF184031-6A7E-4819-A169-8C044A28F33F

Q37250253-AF82D9FC-39F0-4AB9-A8AE-48C728FFEBC9

P2860

Q37250253-011552B4-984C-4FE1-A989-8F00CA9843C3

Q37250253-025F1582-9612-42FF-8F35-3258A3B23703

Q37250253-0859F688-B1EB-46F8-B760-44EF02082E43

Q37250253-0BD280E1-2640-46E1-8AE0-3D3735CCA0DE

Q37250253-0DA51381-9C47-4E2C-8B13-0B14E8F26A73

Q37250253-10F411B3-A4C7-4602-8468-20FDB306E1BB

Q37250253-1909FDE1-5549-467E-8AA2-66AE2C324862

Q37250253-1A656B36-97E9-4515-BF13-29DAA486BAC2

Q37250253-1C3B86C6-167F-43C2-9137-08342C7F285B

Q37250253-2041FFFA-9B7B-4689-80BA-96497A053AA4

P2888

Q37250253-783AA4E5-E849-44E2-80C2-68272F4E5E26

P304

Q37250253-E11800A8-6B14-4CA4-B426-EA3BFF873B97

P31

Q37250253-80157b71-41da-458a-aa98-5d78a660898d

Q37250253-EA70C5CD-439C-4A2A-992F-734FFE243ED7

P356

Q37250253-26A64E30-A223-460D-BF41-DE1AC6957BA1

P433

Q37250253-A18C29C2-5D0B-4F6D-B8CE-437F77AD1B8C

P478

Q37250253-2FB96795-5A07-418F-9E55-8588F218F4F5

P577

Q37250253-DB4D9513-F52B-4C4B-B409-2D6B942D93E7

P5875

Q37250253-597FA0E9-8291-4603-8639-A7A25829F635

P698

Q37250253-4B5286B2-3801-44E9-8972-026CD7A2A905

P932

Q37250253-0DF4CF53-7327-4A29-BDF4-878D83961318

P356

S11060-009-9919-Z

P1433

Journal of Neuro-Oncology

P1476

Molecular properties of CD133+ ...... actory recurrent brain tumors.

@en

P2093

Cho-Lea Tso

http://www.w3.org/2001/XMLSchema#string

David H Nguyen

http://www.w3.org/2001/XMLSchema#string

Jason Y Liu

http://www.w3.org/2001/XMLSchema#string

Jonathan L Tso

http://www.w3.org/2001/XMLSchema#string

Kenneth Chung

http://www.w3.org/2001/XMLSchema#string

Linda M Liau

http://www.w3.org/2001/XMLSchema#string

On Ying Liu

http://www.w3.org/2001/XMLSchema#string

Paul S Mischel

http://www.w3.org/2001/XMLSchema#string

Peter Shitaku

http://www.w3.org/2001/XMLSchema#string

Qinghai Liu

http://www.w3.org/2001/XMLSchema#string

P2860

HSulf-1 inhibits angiogenesis and tumorigenesis in vivo

The homeobox gene GAX activates p21WAF1/CIP1 expression in vascular endothelial cells through direct interaction with upstream AT-rich sequences

c-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cbeta) gene

Brain lipid-binding protein is a direct target of Notch signaling in radial glial cells

Cancerous stem cells can arise from pediatric brain tumors

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Identification of human brain tumour initiating cells

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Identification of stem cells in small intestine and colon by marker gene Lgr5

Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization

P2888

s11060-009-9919-z

P304

1-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-009-9919-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26240210

http://www.w3.org/2001/XMLSchema#string

P698

19468690

http://www.w3.org/2001/XMLSchema#string

P932

2705704

http://www.w3.org/2001/XMLSchema#string